PNKD
protein-codingPNKD metallo-beta-lactamase domain containing, the group of MicroRNA protein coding host genes|MBL domain containing glyoxalase 2 subfamily|Mitochondrial respiratory chain complex assembly factors
Gene summary
This gene is thought to play a role in the regulation of myofibrillogenesis. Mutations in this gene have been associated with the movement disorder paroxysmal non-kinesigenic dyskinesia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~77.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0007661
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0007326
Submitter: Genomics England PanelApp
Inheritance Pattern: AD
Disease ID:MONDO:0700089
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0007326
Submitter: Orphanet
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PNKD variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_015488.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 7 | 93 | 5 | 105 | ||
| missense | 3 | 282 | 29 | 1 | 315 | |
| nonsense | 15 | 15 | ||||
| start loss | 2 | 2 | ||||
| frameshift | 20 | 1 | 21 | |||
| splice donor/acceptor (+/-2bp) | 15 | 15 | ||||
| Total | 0 | 3 | 341 | 123 | 6 | 473 |
Highest pathogenic variant AF is 0.000022309063
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_056303.3 | 10 | MANE Select | |
| Ensembl | ENSP00000273077.4 | 10 | MANE Select | |
| RefSeq | NP_001070867.1 | 3 | Standard | |
| RefSeq | NP_072094.1 | 9 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione
- regulation of synaptic transmission, dopaminergic
- regulation of dopamine metabolic process
- negative regulation of neurotransmitter secretion
- neuromuscular process controlling posture
Molecular Function
- hydroxyacylglutathione hydrolase activity
- protein binding
- metal ion binding
Cellular Component
- nucleus
- mitochondrion
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000273077
- Coding exons
- 10
- Length
- 76402
- Individuals with no LoFs
- 125681
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 67
- Defined
- 125748
- p
- 0.000266
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.323 | 215 | 229 | 0.940 | 0.0000145 | 2413 |
| Missense (PolyPhen) | 56 | 64.772 | 0.86457 | 684 | ||
| Synonymous | 1.08 | 80 | 93.3 | 0.857 | 0.00000527 | 823 |
| Loss of Function | 1.11 | 14 | 19.2 | 0.728 | 9.19e-7 | 219 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.00039 | 0.00035 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00044 | 0.00040 | rare |
| South Asian | 0.00020 | 0.00020 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Probable hydrolase that plays an aggravative role in the development of cardiac hypertrophy via activation of the NF-kappa- B signaling pathway. {ECO:0000250}.;
- Disease
- DISEASE: Dystonia 8 (DYT8) [MIM:118800]: A paroxysmal non- kinesigenic dystonia/dyskinesia. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. Dystonia type 8 is characterized by attacks of involuntary movements brought on by stress, alcohol, fatigue or caffeine. The attacks generally last between a few seconds and four hours or longer. The attacks may begin in one limb and spread throughout the body, including the face. {ECO:0000269|PubMed:15262732, ECO:0000269|PubMed:15824259, ECO:0000269|PubMed:16632198, ECO:0000269|PubMed:16717228, ECO:0000269|PubMed:16972263}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.258
Intolerance Scores
- LoFtool
- 0.156
- RVIS EVS
- -0.36
- RVIS percentile EVS
- 29.31
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.998
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |